16 results
diabetes dm2 summary pathophysiology antiarrhythmics cardiology classes classification cva dosing inhibitors oral overview thrombolytics tpa agonists atorvastatin combination combo comparison
Diabetes Combination Tablets - Estimated A1c Lowering Metformin + DPP4 • Janumet (metformin + sitagliptin) •
Synjardy (metformin + empagliflozin ... (linagliptin + empagliflozin ... ) • Qtern (dapagliflozin ... Tablets #Oral #DM2 #Pharmacology ... #Pills #Endocrinology
SGLT2 Inhibitors - Pharmacology Summary Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
SGLT2 Inhibitors - Pharmacology ... Eric Strong @DrEricStrong ... - Strong Medicine ... SGLT2 #Inhibitors #Pharmacology ... DM2 #diabetes #endocrinology
Mechanism of Action for Common Diabetes Medications • SGLT2i (Dapagliflozin) • TZD (Pioglitazone) • Biguanides (Metformin)
• SGLT2i (Dapagliflozin ... #Medications #pharmacology ... pathophysiology #endocrinology
Sulfonylureas - Pharmacology Summary Mechanisms of Action: Binds to the ATP-sensitive potassium channel in pancreatic beta cells,
Sulfonylureas - Pharmacology ... Eric Strong @DrEricStrong ... - Strong Medicine ... Sulfonylureas #Pharmacology ... DM2 #diabetes #endocrinology
Insulin Comparison Chart - Peak and Duration Inhaled, Rapid-acting (Analog), Regular, Intermediate-Acting (NPH), Detemir, Glargine, Degludec - Stephen
Degludec - Stephen Stone ... Peak #Duration #Pharmacology ... #Endocrinology
Atorvastatin. HMG-CoA reductase inhibitor (statin) for dyslipidemia and MI/stroke prevention. 2nd most prescribed drug in the
HMG-CoA reductase ... dyslipidemia and MI/stroke ... #Pharmacology #Atorvastatin
Alteplase (t-PA) for Acute Ischemic Stroke: Dosage, Mixing, and Administration Instructions #TPA #Thrombolytics #Stroke #CVA #Dosage #Dosing
Acute Ischemic Stroke ... Thrombolytics #Stroke ... #CVA #Dosage #Dosing ... #Instructions #Pharmacology
tPA Code Stroke Dosing Chart Total Dose = 0.9 mg/kg (maximum dose =90 mg) - give 10%
tPA Code Stroke ... #Dosing #Dose #CVA ... Thrombolytics #Stroke ... #Pharmacology
Metformin Pharmacology Summary Mechanisms of Action: • Suppresses gluconeogenesis by the liver • Increases insulin-mediated glucose utilization
Metformin Pharmacology ... Eric Strong @DrEricStrong ... - Strong Medicine ... #Metformin #Pharmacology ... DM2 #diabetes #endocrinology
DPP-4 Inhibitors - Pharmacology Summary Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
4 Inhibitors - Pharmacology ... Eric Strong @DrEricStrong ... - Strong Medicine ... DPP4 #Inhibitors #Pharmacology ... DM2 #diabetes #endocrinology
No results found for "Morulae empagliflozin cta stroke pharmacology endocrinology"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #Morulae #empagliflozin #cta #stroke #pharmacology #endocrinology